Malaria
📧 Sign up to get email alerts when something new happens for Malaria.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-02-17Clinical Trial Update: ACT MALI: Treatment of Malaria Based on Combination Therapies [Phase 4]
Phase 4 trial update on ACT MALI for malaria, evaluating artemisinin-based combination therapies. The study has completed.
-
CLINICAL_TRIALS trial_result · 2010-02-08Clinical Trial Update: Effects of Insecticide Treated Bednets on Child Morbidity and Mortality [NA]
A completed clinical trial assessed whether insecticide-treated bednets reduce malaria morbidity and overall mortality in children.
-
CLINICAL_TRIALS trial_result · 2010-02-03Clinical Trial Update: Efficacy of Amodiaquine in the Treatment of Uncomplicated Falciparum Malaria in Young Children of Burkina Faso [Phase 2]
Phase 2 clinical trial in Burkina Faso evaluated the efficacy of amodiaquine for uncomplicated falciparum malaria in young children; the stu…
-
CLINICAL_TRIALS trial_result · 2010-01-14Clinical Trial Update: Assessment of Anaemia Attributable to Schistosomiasis in School Children in Kenya: Mechanisms and Effect of Treatment
A completed clinical trial assessing the mechanisms and impact of treatment on anemia attributable to schistosomiasis in Kenyan schoolchildr…
-
CLINICAL_TRIALS trial_result · 2009-12-21Clinical Trial Update: A Comparative Safety and Activity Study With Ferroquine Associated With Artesunate Versus Amodiaquine Associated With Artesunate in African Adult Patients With Uncomplicated Malaria [Phase 1, Phase 2]
A completed Phase 1/2 trial comparing ferroquine–artesunate versus amodiaquine–artesunate in African adults with uncomplicated malaria to ev…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-11-18FDA Approved: MEFLOQUINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for mefloquine hydrochloride from Teva Pharmaceuticals USA, Inc. The approval relates to a labeling …
-
FDA approval · 2009-10-19FDA Approved: MEFLOQUINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for mefloquine hydrochloride from Chartwell RX, LLC under an ANDA, updating regulatory status fo…
-
CLINICAL_TRIALS research · 2009-09-22Clinical Trial Update: Evaluation of the Public Health Impact of Seasonal Intermittent Preventive Treatment (IPT) in Children in Senegal [Phase 4]
Phase 4 clinical trial update evaluating the public health impact of seasonal intermittent preventive treatment for malaria in children in S…
-
CLINICAL_TRIALS trial_result · 2009-09-16Clinical Trial Update: Safety and Efficacy Study of Artesunate and Mefloquin in Children With Uncomplicated Malaria [Phase 4]
A completed Phase 4 trial evaluated the safety and efficacy of artesunate plus mefloquine in children with uncomplicated malaria.
-
FDA label_change · 2009-09-02FDA Approved: MALARONE — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Malarone (atovaquone and proguanil hydrochloride) manufactured by GlaxoSmithKline LLC.
-
CLINICAL_TRIALS trial_result · 2009-07-14Clinical Trial Update: Clinical Evaluation of Insect Repellent and Insecticide Treated Nets in Lao PDR [Phase 3]
Phase 3 clinical trial in Lao PDR evaluating insect repellent and insecticide-treated nets for the prevention of malaria, dengue fever, and …
-
CLINICAL_TRIALS trial_result · 2009-07-02Clinical Trial Update: Sulfadoxine- Pyrimethamine Versus Weekly Chloroquine for Malaria Prevention in Children With Sickle Cell Anemia [Phase 3]
A Phase 3 clinical trial comparing sulfadoxine-pyrimethamine to weekly chloroquine for malaria prevention in children with sickle cell disea…
-
FDA approval · 2009-06-12FDA Approved: MEFLOQUINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for mefloquine hydrochloride from Teva Pharmaceuticals USA, Inc. under an ANDA.
-
CLINICAL_TRIALS trial_result · 2009-06-10Clinical Trial Update: Efficacy of Methylene Blue for Malaria Treatment in Adults of Burkina Faso: Proof of Principle Study in Semi-Immune Adults of Burkina Faso in the Frame of the A8 Project of the SFB 544 [Phase 2]
Phase 2 proof-of-principle trial in semi-immune adults in Burkina Faso evaluated the efficacy of methylene blue for treating malaria.
-
CLINICAL_TRIALS trial_result · 2009-06-04Clinical Trial Update: Can Treatment of Malaria be Restricted to Parasitologically Confirmed Malaria?
A completed clinical trial evaluated whether malaria treatment could be restricted to parasitologically confirmed cases rather than treating…
-
CLINICAL_TRIALS trial_result · 2009-04-21Clinical Trial Update: A Phase 1 Study To Estimate The Relative Bioavailability Of Fixed Combination Tablets Of Azithromycin And Chloroquine Compared To Co-Administered Individual Tablets Of Azithromycin And Chloroquine [Phase 1]
This Phase 1 study evaluated the relative bioavailability of a fixed-dose combination tablet of azithromycin and chloroquine compared with c…
-
CLINICAL_TRIALS trial_result · 2009-04-17Clinical Trial Update: Investigation of the Efficacy of Quinine Sulphate Administered Via Taste-Masked Pellets to Children With Falciparum Malaria [Phase 2]
A Phase 2 clinical trial evaluated the efficacy of taste-masked Quinine Sulphate pellets in children with falciparum malaria; the study has …
-
FDA approval · 2009-04-07FDA Approved: COARTEM — Original Application (Novartis Pharmaceuticals Corporation)
FDA approved COARTEM, a fixed-dose combination of artemether and lumefantrine, under an Original Application by Novartis for the treatment o…
-
CLINICAL_TRIALS trial_result · 2009-02-26Clinical Trial Update: ACT for the Home Management in Malagasy Children
A completed clinical trial evaluated home-based management of fever and suspected malaria in Malagasy children using artemisinin-based combi…
-
CLINICAL_TRIALS trial_result · 2009-02-04Clinical Trial Update: Efficacy of Fosmidomycin-Clindamycin for Treating Malaria in Gabonese Children [Phase 3]
A Phase 3 trial evaluating fosmidomycin-clindamycin for malaria in Gabonese children has completed. The update reports efficacy results from…
-
CLINICAL_TRIALS trial_result · 2009-02-04Clinical Trial Update: The Use of Homeopathic-Based Treatment Approaches to Reduce the Prevalence of Malaria in Depressed Communities [Phase 4]
Phase 4 clinical trial evaluating homeopathic-based treatment approaches to reduce malaria prevalence in communities. The study status is co…
-
CLINICAL_TRIALS trial_result · 2009-02-03Clinical Trial Update: Safety and Efficacy of Methylene Blue Combined With Amodiaquine or Artesunate for Malaria Treatment in Children of Burkina Faso [Phase 2]
Phase 2 trial results assess the safety and efficacy of methylene blue combined with amodiaquine or artesunate for treating malaria in child…
-
FDA approval · 2009-01-15FDA Approved: MEFLOQUINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for mefloquine hydrochloride submitted by Chartwell RX, LLC.
-
CLINICAL_TRIALS trial_result · 2009-01-07Clinical Trial Update: Assessment of Biologic Parameters in Preparation for Future Malaria Vaccine Trials in Don gu Bougou, Mali
NIAID-sponsored study assessing biologic parameters in preparation for future malaria vaccine trials in Don gu Bougou, Mali, has been termin…
-
FDA approval · 2008-12-18FDA Approved: MALARONE — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Malarone (atovaquone and proguanil hydrochloride) submitted by GlaxoSmithKline LLC.